Page 236 - Clinical Small Animal Internal Medicine
P. 236

204  Section 3  Cardiovascular Disease

            prevent worsening of ventricular arrhythmias and low   it should not be combined with other beta‐blockers. It is
  VetBooks.ir  magnesium  concentrations  may  result  in  hypokalemia   the first choice for boxers with arrhythmogenic right
                                                              ventricular cardiomyopathy.
            that is nonresponsive despite adequate supplementation.
                                                                Amiodarone is a drug that appears to be very effective
            Other alternatives, such as synchronized cardioversion,
            esmolol or precordial thump, can be attempted if the   for refractory arrhythmias but it has been reported to
            above therapies fail to improve hemodynamic stability.  have significant and severe side‐effects. The low end of
             Precordial thump for control of ventricular arrhyth-  the dosage range should be used first and uptitrated only
            mias was previously recommended as an initial maneu-  if necessary. There are many side‐effects to the chronic
            ver in the treatment of ventricular tachycardia (VT) or   use of amiodarone. It may cause a hepatopathy, so liver
            ventricular fibrillation, but is now only considered for   enzymes should be evaluated before starting and peri-
            patients with witnessed, monitored and unstable VT   odically while receiving amiodarone and any time ano-
            resulting in cardiac arrest/asystole. A precordial thump   rexia develops. It may also cause neutropenia of unknown
            is a very carefully aimed blow with the fist to the chest   clinical significance and neurologic signs, and/or ataxia,
            with the intent to interrupt a life‐threatening rhythm.   especially at higher doses and with prolonged use.
            The thump is thought to produce an electrical depo-  Amiodarone can be combined with a beta‐blocker.
            larization of 2–5 joules, but is only effective if used   Additionally, it does not appear to have significant nega-
            near the onset of ventricular fibrillation. The precor-  tive inotropic effects and is thus safe to use in patients
            dial thump for VT remains controversial as precordial   with ventricular dysfunction. The authors have not used
            blows can trigger ventricular fibrillation (i.e., commo-  this drug in cats.
            tio cordis). It should only be used for asystole or ven-  Mexiletine is another useful antiarrhythmic agent, but
            tricular fibrillation when a defibrillator is unavailable   has become increasingly more difficult to find for veteri-
            for use.                                          nary patients and has several times come off the market.
                                                              It is often used in combination with atenolol or sotalol
                                                              for refractory arrhythmias or as an initial antiarrhythmic
            Chronic Therapy of Ventricular Tachycardia
                                                              agent for dogs with systolic dysfunction. The authors
            All chronic antiarrhythmic agents have the potential to   have not used mexiletine as an antiarrhythmic in cats.
            act as proarrhythmics, so their use should be monitored.   Although antiarrhythmics are usually successful at
            This is ideally done by obtaining a 24‐hour Holter   controlling clinical signs in animals with ventricular
            recording before and 8–15 days after initiation of antiar-  arrhythmias, their ability to decrease the risk for sudden
            rhythmics. If  worsening  arrhythmias develop,  then  a   death is uncertain. Recently, the use of implantable car-
            proarrhythmic effect should be considered as an under-  dioverter defibrillators (ICD) has been investigated in
            lying etiology. In addition, all antiarrhythmic agents have   dogs. These devices, which have similarities with pace-
            significant toxicity profiles. In both dogs and cats, the   makers, are extensively used in people to terminate life‐
            authors’ first choice for chronic ventricular arrhythmia   threatening episodes of ventricular tachycardia or
            therapy is sotalol. Although not a pure beta‐blocker,   fibrillation with high‐energy electrical shocks. Accurate
            sotalol has significant beta‐blocking effects, and should   detection of arrhythmias amenable to electrical therapy
            therefore be used with caution and slowly uptitrated in   is, however, still challenging in dogs. Advances in ICD
            dogs with significant ventricular systolic dysfunction,   technology and programmability  may help to expand
            such as those with dilated cardiomyopathy. In addition,   their use in veterinary medicine.
   231   232   233   234   235   236   237   238   239   240   241